This piece reports that sexual dysfunctions are more common among individuals with paraphilias, with higher odds of erectile dysfunction, premature ejaculation, and female orgasmic disorder, particularly among those with paraphilic disorders. It also outlines how paraphilic interests and disorders relate to pornography exposure and early sexual experiences, based on a large Hungarian sample.

This topic is of interest to psychology readers because it highlights patterns of comorbidity between atypical sexual interests and sexual functioning, underscoring the complexity of how sexual concerns intersect with identity, behavior, and distress.

Article Title: Sexual dysfunctions are significantly more common in people with paraphilias

Link to PsyPost Article: https://nolinkpreview.com/www.psypost.org/sexual-dysfunctions-are-significantly-more-common-in-people-with-paraphilias/

#paraphilias #sexualdysfunction #erectiledysfunction #prematureejaculation #femaleorgasmicdisorder #paraphilicdisorder #sexualhealth #psychologyresearch #crosssectionalstudy #Hungary

Learn to Identify Epidemiologic Study Designs: Case Series, Cohort, Case-Control & More

Master epidemiology by matching vignettes to the correct study designs. Learn key clues to identify cross-sectional, cohort, case-control, twin, adoption, and ecological studies — ideal for medical students and public health professionals.

mymedschool.org

[STUDY] Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment

#cannabis #cancer #pain #MedicalCannabis #MedicalMarijuana #PlantsNotPills #JAMA #research #CrossSectionalStudy #studies #medicine #oncology #science #ScienceMastodon https://jamanetwork.com/journals/jamaoncology/fullarticle/2799132

Medical Marijuana Legalization and Opioid and Pain Outcomes in Patients Receiving Cancer Treatment

This cross-sectional study examines the association between medical marijuana legalization and differences in opioid-related and pain-related outcomes in adults with newly diagnosed cancer who are undergoing anticancer treatment.